These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27887708)

  • 1. Pulsatile gonadotropin-releasing hormone therapy in persistent amenorrheic weight-recovered anorexia nervosa patients.
    Germain N; Fauconnier A; Klein JP; Wargny A; Khalfallah Y; Papastathi-Boureau C; Estour B; Galusca B
    Fertil Steril; 2017 Feb; 107(2):502-509. PubMed ID: 27887708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis.
    Tranoulis A; Laios A; Pampanos A; Yannoukakos D; Loutradis D; Michala L
    Fertil Steril; 2018 Apr; 109(4):708-719.e8. PubMed ID: 29605411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
    Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
    García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea.
    Christou F; Pitteloud N; Gomez F
    Gynecol Endocrinol; 2017 Aug; 33(8):598-601. PubMed ID: 28277105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea.
    Giusti M; Torre R; Traverso L; Cavagnaro P; Attanasio R; Giordano G
    Fertil Steril; 1988 May; 49(5):797-801. PubMed ID: 3129313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome.
    Dubourdieu S; Fréour T; Dessolle L; Barrière P
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):45-8. PubMed ID: 23298894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin.
    Matsuzaki T; Azuma K; Irahara M; Yasui T; Aono T
    Fertil Steril; 1994 Dec; 62(6):1143-9. PubMed ID: 7957976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Reprod Biol Endocrinol; 2016 Apr; 14(1):24. PubMed ID: 27129705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.